IL6 and cancer: The decrease in their proliferation potential may be attributed to the secretion of several inflammatory molecules, such as IL-1β, IL-6, IL-8, IL-10, and matrix metallo-proteinases (MMPs) by cancer cells, which have adverse effects on the neighboring cells in the niche.